Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001082858 | SCV000166224 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000162464 | SCV000212826 | likely benign | Hereditary cancer-predisposing syndrome | 2014-08-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000162464 | SCV000537454 | likely benign | Hereditary cancer-predisposing syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000122960 | SCV000601554 | likely benign | not provided | 2022-12-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000507567 | SCV000729045 | benign | not specified | 2015-06-24 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000507567 | SCV000917773 | likely benign | not specified | 2019-08-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000122960 | SCV001152297 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | MSH6: BP4, BP7 |
Genetic Services Laboratory, |
RCV000507567 | SCV002071314 | likely benign | not specified | 2019-10-22 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000162464 | SCV002535784 | likely benign | Hereditary cancer-predisposing syndrome | 2021-04-12 | criteria provided, single submitter | curation | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149836 | SCV003838321 | likely benign | Breast and/or ovarian cancer | 2022-05-03 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003315812 | SCV004016002 | likely benign | Lynch syndrome 5 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000507567 | SCV004243098 | likely benign | not specified | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004530047 | SCV004741498 | likely benign | MSH6-related disorder | 2023-08-07 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
All of Us Research Program, |
RCV003997398 | SCV004834489 | likely benign | Lynch syndrome | 2024-01-11 | criteria provided, single submitter | clinical testing |